Juvenile polyposis syndrome in children: The impact of SMAD4 and BMPR1A mutations on clinical phenotype and polyp burden

Shlomi Cohen,Anat Yerushalmy‐Feler,Isabel Rojas,Claudia Phen,David A. Rudnick,Colleen B. Flahive,Steven H. Erdman,Ramit Magen‐Rimon,Ivana Copova,Thomas Attard,Andrew Latchford,Warren Hyer
DOI: https://doi.org/10.1002/jpn3.12257
2024-05-29
Journal of Pediatric Gastroenterology and Nutrition
Abstract:Objective A constitutional disease‐causing variant (DCV) in the SMAD4 or BMPR1A genes is present in 40%–60% of patients with juvenile polyposis syndrome (JPS). The aim of this study was to characterize the clinical course and polyp burden in children with DCV‐positive JPS compared to DCV‐negative JPS. Methods Demographic, clinical, genetic, and endoscopic data of children with JPS were compiled from eight international centers in the ESPHGAN/NASPGHAN polyposis working group. Results A total of 124 children with JPS were included: 69 (56%) DCV‐negative and 55 (44%) DCV‐positive (53% SMAD4 and 47% BMPR1A) with a median (interquartile range [IQR]) follow‐up of 4 (2.8–6.4) years. DCV‐positive children were diagnosed at an older age compared to DCV‐negative children [12 (8–15.7) years vs. 5 (4–7) years, respectively, p
pediatrics,gastroenterology & hepatology,nutrition & dietetics
What problem does this paper attempt to address?